+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Synthetic Hormones Market - Global Forecast 2026-2032- Product Image
Synthetic Hormones Market - Global Forecast 2026-2032- Product Image
Sale

Synthetic Hormones Market - Global Forecast 2026-2032

  • Report

  • 188 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5533197
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Synthetic Hormones Market is projected to reach USD 9.91 Billion in 2026. It is expected to continue growing at a CAGR of 8.01%, reaching USD 15.78 Billion by 2032.

Synthetic hormones are engineered endocrine therapies used to replace, regulate, suppress, or mimic naturally occurring hormones across high-value therapeutic areas, including thyroid disease, diabetes, reproductive health, menopause management, adrenal insufficiency, growth disorders, oncology support, and gender-affirming care. The category spans small-molecule steroids, peptide hormones, recombinant biologics, and long-acting analogs delivered through oral, injectable, transdermal, intranasal, vaginal, and implantable formats.

Market momentum is supported by measurable healthcare fundamentals: rising diagnosis of endocrine and metabolic disorders, population aging, broader access to assisted reproductive technologies, and guideline-based use of hormone replacement and suppression therapies. Regulatory oversight from agencies such as the U.S. FDA, the European Medicines Agency, the World Health Organization, and national pharmacovigilance bodies continues to shape product quality, labeling, risk management, bioequivalence standards, and post-market safety expectations.

Transformative Shifts in the Synthetic Hormones Landscape

The synthetic hormones landscape is shifting from volume-led generic competition toward differentiated delivery, adherence-focused formulations, and evidence-based personalization. Manufacturers are prioritizing long-acting injectables, transdermal systems, lower-dose regimens, patient-friendly devices, and combination approaches that can improve convenience while maintaining clinically validated efficacy and safety.

At the same time, supply chain resilience has become a strategic priority. Hormone therapies often depend on specialized active pharmaceutical ingredient manufacturing, stringent impurity control, controlled storage conditions, cold-chain capabilities for selected biologics, and consistent quality documentation. Companies that align formulation innovation with regulatory-grade manufacturing, pharmacovigilance, serialization, and payer evidence are best positioned to compete in the synthetic hormone therapeutics landscape.

Cumulative Impact of Artificial Intelligence on Synthetic Hormones

Artificial intelligence is creating cumulative advantages across synthetic hormone discovery, manufacturing, clinical development, and commercialization. AI-enabled molecular modeling can support analog optimization, while machine learning can improve process analytics, impurity prediction, batch monitoring, quality deviation analysis, and demand forecasting. In clinical and real-world settings, AI can help identify adherence patterns, safety signals, drug-utilization trends, and patient segments that may benefit from tailored dosing or delivery strategies.

The opportunity is significant, but adoption must remain grounded in validated science and regulated workflows. Industry leaders need explainable models, auditable data pipelines, GxP-compliant validation, cybersecurity controls, and privacy protections aligned with HIPAA, GDPR, and emerging AI governance requirements. In synthetic hormones, AI is most valuable when it strengthens clinical evidence, quality assurance, pharmacovigilance, and patient safety rather than replacing expert judgment.

Key Regional Insights for Synthetic Hormones

Asia-Pacific is a high-growth region for synthetic hormones, supported by large patient populations, expanding endocrine diagnostics, rising fertility treatment adoption, and strong pharmaceutical manufacturing capacity in China and India, while Japan, South Korea, and Australia contribute advanced regulatory systems and demand for innovative delivery formats. North America remains a leading market due to established reimbursement pathways, high diagnosis rates, specialist access, strong pharmacovigilance infrastructure, and an active innovation base across endocrinology, fertility, diabetes, women’s health, and gender-affirming care.

Europe is shaped by EMA-led regulatory rigor, national health technology assessment, biosimilar and generic medicine pathways, and strong demand for cost-effective, evidence-backed therapies across the European Union and the United Kingdom. Latin America, led by Brazil and Mexico, is expanding through public-sector access programs, private healthcare growth, and improving specialty care networks, though affordability, regulatory timelines, and supply continuity remain important. The Middle East is gaining momentum through GCC healthcare investment, centralized procurement, and specialty endocrinology expansion, while Africa presents long-term access opportunities tied to essential medicines availability, diagnostics, cold-chain capacity, trained clinicians, and distribution infrastructure.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN markets are benefiting from healthcare modernization, regional regulatory collaboration, growing private hospital networks, and rising demand for contraception, thyroid therapies, fertility care, menopause management, and diabetes-related hormone products. The GCC is advancing through hospital expansion, centralized procurement, local health-system transformation programs, and investment in specialty endocrinology and reproductive medicine, making quality assurance, compliant labeling, and tender readiness essential for suppliers.

The European Union emphasizes harmonized regulatory review, pharmacovigilance, health technology assessment, and cost-effectiveness, creating opportunities for high-quality generics, biosimilars, and differentiated delivery technologies. BRICS economies combine large patient bases with increasing domestic manufacturing capacity, particularly in India, China, and Brazil, while Russia and South Africa highlight the importance of localization, procurement access, and essential medicine supply. G7 markets continue to set benchmarks for clinical evidence, innovation, safety monitoring, and reimbursement scrutiny, while NATO countries are increasingly attentive to pharmaceutical supply security, stockpiling, trusted suppliers, and reliable access to essential hormone therapies.

Key Country Insights for Synthetic Hormones

The United States leads synthetic hormone innovation through FDA-regulated drug development, strong specialty care infrastructure, and demand across diabetes, reproductive health, menopause, thyroid disease, growth disorders, and gender-affirming care. Canada emphasizes publicly guided access, formulary evaluation, and safety monitoring, while Mexico is expanding through private care growth, public procurement, and proximity to North American pharmaceutical supply chains. Brazil is the largest Latin American opportunity, supported by public procurement, domestic manufacturing, and demand for reproductive, thyroid, and metabolic therapies, and Australia benefits from strong clinical governance, reimbursement evaluation, and advanced endocrine care pathways.

In Europe, the United Kingdom, Germany, France, Italy, and Spain combine mature prescribing practices with payer scrutiny, pharmacovigilance, and demand for both branded and generic hormone therapies, including products used in menopause care, contraception, fertility, thyroid disease, and oncology-adjacent hormone suppression. Russia remains a sizeable market where localization, regulatory navigation, and supply continuity matter. China and India are central to both demand and production, with China scaling specialty care and chronic disease management and India contributing major generic, formulation, and API capacity. Japan and South Korea prioritize quality, aging-related endocrine care, stringent regulatory compliance, and advanced formulations across highly regulated healthcare systems.

Actionable Recommendations for Synthetic Hormone Industry Leaders

Industry leaders should prioritize clinically meaningful differentiation, not formulation novelty alone. Investment should focus on delivery systems that improve adherence, reduce dosing burden, support consistent exposure, and address documented patient needs in endocrine, reproductive, metabolic, and oncology-adjacent care. Evidence generation should include real-world outcomes, safety monitoring, patient-reported outcomes, drug-utilization analysis, and payer-relevant data.

Manufacturers should strengthen supply chain redundancy for APIs, excipients, device components, packaging, and cold-chain products where applicable. Commercial teams should localize market access strategies by region, prepare for pricing pressure in mature markets, and build partnerships with endocrinologists, gynecologists, fertility specialists, primary care networks, pharmacists, and digital health platforms. AI should be deployed with strong governance to enhance quality, forecasting, pharmacovigilance, medical information, and compliant clinical decision support.

Research Methodology

This executive summary is based on a structured review of publicly available and verifiable sources, including regulatory guidance, drug labels, clinical practice guidelines, pharmacovigilance principles, public health data, and healthcare system trends. Core reference points include agencies and institutions such as the U.S. FDA, European Medicines Agency, World Health Organization, International Council for Harmonisation, national health authorities, and recognized medical societies in endocrinology, diabetes care, reproductive medicine, menopause care, and oncology support.

The methodology integrates qualitative market assessment with therapeutic-area analysis, regional demand indicators, regulatory requirements, manufacturing considerations, access dynamics, and technology adoption trends. No unsupported market-size, market-share, or forecasting claims are used. Insights are synthesized to reflect evidence-backed patterns in synthetic hormone development, access, quality, safety, and commercialization.

Conclusion

The synthetic hormones market is entering a more disciplined phase defined by safety, access, personalization, and manufacturing resilience. Opportunities remain strong across endocrine disorders, reproductive health, diabetes-related hormone therapies, menopause care, thyroid disease, and specialty indications, but success depends on clinical evidence, regulatory compliance, patient-centered design, and reliable supply.

Organizations that combine validated science, differentiated delivery, robust supply chains, AI-enabled operational excellence, and region-specific access strategies will be positioned to create long-term value. As healthcare systems demand better outcomes, stronger safety assurance, and greater affordability, synthetic hormone leaders must demonstrate measurable therapeutic benefit while maintaining the highest standards of quality, transparency, and patient safety.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Synthetic Hormones Market, by Type
7.1. Introduction
7.2. Estrogens
7.3. Progestins
7.4. Combined HRT
7.5. Androgens/Testosterone
7.6. Gonadotropins
7.7. Thyroid hormones
8. Synthetic Hormones Market, by Technology
8.1. Introduction
8.2. Chemical Synthesis
8.3. Recombinant DNA Technology
9. Synthetic Hormones Market, by Route of Administration
9.1. Introduction
9.2. Oral
9.3. Transdermal
9.4. Vaginal
9.5. Injectable
10. Synthetic Hormones Market, by Application
10.1. Introduction
10.2. Contraception
10.3. Diabetes
10.4. Growth Hormone Deficiency
10.5. Menopausal Symptoms
10.6. Thyroid Disorders
10.6.1. Hyperthyroidism
10.6.2. Hypothyroidism
11. Synthetic Hormones Market, by End User
11.1. Introduction
11.2. Fertility Clinics
11.3. Homecare Settings
11.4. Hospitals
12. Synthetic Hormones Market, by Sales Channel
12.1. Introduction
12.2. Hospital Pharmacy
12.3. Retail Pharmacy
12.4. Online Pharmacy
13. Synthetic Hormones Market, by Region
13.1. Asia-Pacific
13.2. Europe
13.3. North America
13.4. Latin America
13.5. Africa
13.6. Middle East
14. Synthetic Hormones Market, by Group
14.1. NATO
14.2. G7
14.3. BRICS
14.4. European Union
14.5. ASEAN
14.6. GCC
15. Synthetic Hormones Market, by Country
15.1. China
15.2. United States
15.3. Japan
15.4. India
15.5. Germany
15.6. United Kingdom
15.7. Australia
15.8. France
15.9. South Korea
15.10. Italy
15.11. Canada
15.12. Russia
15.13. Brazil
15.14. Mexico
15.15. Spain
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
16.3.1. Concentration Ratio (CR)
16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Abbott Laboratories
17.2. AbbVie Inc.
17.3. Amneal Pharmaceuticals, Inc.
17.4. AstraZeneca PLC
17.5. Aurobindo Pharma Ltd.
17.6. Bayer AG
17.7. Besins Healthcare
17.8. Dr. Reddy’s Laboratories
17.9. Eli Lilly and Company
17.10. Endo International plc
17.11. Ferring B.V.
17.12. Gedeon Richter Plc
17.13. Gilead Sciences Inc.
17.14. IBSA Group
17.15. Ipsen S.A.
17.16. Johnson & Johnson Services Inc.
17.17. Lupin Limited
17.18. Mayne Pharma Group
17.19. Merck & Co. Inc.
17.20. Novartis AG
17.21. Novo Nordisk A/S
17.22. Organon & Co.
17.23. Pfizer Inc.
17.24. Sanofi SA
17.25. Sun Pharmaceutical Industries Ltd.
17.26. Teva Pharmaceutical Industries Ltd.
17.27. Theramex
17.28. TherapeuticsMD Inc.
17.29. Viatris Inc.
17.30. Zydus Lifesciences Ltd.
List of Figures
FIGURE 1. GLOBAL SYNTHETIC HORMONES MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL SYNTHETIC HORMONES MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL SYNTHETIC HORMONES MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL SYNTHETIC HORMONES MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL SYNTHETIC HORMONES MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
FIGURE 11. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY SALES CHANNEL, 2025 VS 2032 (%)
FIGURE 17. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL SYNTHETIC HORMONES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL SYNTHETIC HORMONES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL SYNTHETIC HORMONES MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL SYNTHETIC HORMONES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL ESTROGENS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL ESTROGENS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL ESTROGENS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL PROGESTINS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL PROGESTINS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL PROGESTINS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL COMBINED HRT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL COMBINED HRT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL COMBINED HRT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL ANDROGENS/TESTOSTERONE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL ANDROGENS/TESTOSTERONE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL ANDROGENS/TESTOSTERONE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL GONADOTROPINS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL GONADOTROPINS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL GONADOTROPINS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL THYROID HORMONES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL THYROID HORMONES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL THYROID HORMONES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL CHEMICAL SYNTHESIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL CHEMICAL SYNTHESIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL CHEMICAL SYNTHESIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL RECOMBINANT DNA TECHNOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL RECOMBINANT DNA TECHNOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL RECOMBINANT DNA TECHNOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL ORAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL ORAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL TRANSDERMAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL TRANSDERMAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL TRANSDERMAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL VAGINAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL VAGINAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL VAGINAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL INJECTABLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL INJECTABLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL INJECTABLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL CONTRACEPTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL CONTRACEPTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL CONTRACEPTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL DIABETES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL DIABETES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL DIABETES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL GROWTH HORMONE DEFICIENCY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL GROWTH HORMONE DEFICIENCY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL GROWTH HORMONE DEFICIENCY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL MENOPAUSAL SYMPTOMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL MENOPAUSAL SYMPTOMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL MENOPAUSAL SYMPTOMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL THYROID DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL THYROID DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL THYROID DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL HYPERTHYROIDISM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL HYPERTHYROIDISM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL HYPERTHYROIDISM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL HYPOTHYROIDISM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL HYPOTHYROIDISM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL HYPOTHYROIDISM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL FERTILITY CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL FERTILITY CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL FERTILITY CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL HOMECARE SETTINGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL HOMECARE SETTINGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL HOMECARE SETTINGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL HOSPITAL PHARMACY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL HOSPITAL PHARMACY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL HOSPITAL PHARMACY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL RETAIL PHARMACY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL RETAIL PHARMACY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL RETAIL PHARMACY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL ONLINE PHARMACY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL ONLINE PHARMACY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL ONLINE PHARMACY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 85. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 87. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 88. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 89. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 90. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2017-2032 (USD MILLION)
TABLE 91. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 92. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 93. EUROPE SYNTHETIC HORMONES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 94. EUROPE SYNTHETIC HORMONES MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 95. EUROPE SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 96. EUROPE SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 97. EUROPE SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 98. EUROPE SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2017-2032 (USD MILLION)
TABLE 99. EUROPE SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 100. EUROPE SYNTHETIC HORMONES MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 101. NORTH AMERICA SYNTHETIC HORMONES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. NORTH AMERICA SYNTHETIC HORMONES MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 103. NORTH AMERICA SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 104. NORTH AMERICA SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 105. NORTH AMERICA SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 106. NORTH AMERICA SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2017-2032 (USD MILLION)
TABLE 107. NORTH AMERICA SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 108. NORTH AMERICA SYNTHETIC HORMONES MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 109. LATIN AMERICA SYNTHETIC HORMONES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 110. LATIN AMERICA SYNTHETIC HORMONES MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 111. LATIN AMERICA SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 112. LATIN AMERICA SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 113. LATIN AMERICA SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 114. LATIN AMERICA SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2017-2032 (USD MILLION)
TABLE 115. LATIN AMERICA SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 116. LATIN AMERICA SYNTHETIC HORMONES MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 117. AFRICA SYNTHETIC HORMONES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 118. AFRICA SYNTHETIC HORMONES MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 119. AFRICA SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 120. AFRICA SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 121. AFRICA SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 122. AFRICA SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2017-2032 (USD MILLION)
TABLE 123. AFRICA SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 124. AFRICA SYNTHETIC HORMONES MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 125. MIDDLE EAST SYNTHETIC HORMONES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 126. MIDDLE EAST SYNTHETIC HORMONES MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 127. MIDDLE EAST SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 128. MIDDLE EAST SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 129. MIDDLE EAST SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 130. MIDDLE EAST SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2017-2032 (USD MILLION)
TABLE 131. MIDDLE EAST SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 132. MIDDLE EAST SYNTHETIC HORMONES MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 134. NATO SYNTHETIC HORMONES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 135. NATO SYNTHETIC HORMONES MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 136. NATO SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 137. NATO SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 138. NATO SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 139. NATO SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2017-2032 (USD MILLION)
TABLE 140. NATO SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 141. NATO SYNTHETIC HORMONES MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 142. G7 SYNTHETIC HORMONES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 143. G7 SYNTHETIC HORMONES MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 144. G7 SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 145. G7 SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 146. G7 SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 147. G7 SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2017-2032 (USD MILLION)
TABLE 148. G7 SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 149. G7 SYNTHETIC HORMONES MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 150. BRICS SYNTHETIC HORMONES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 151. BRICS SYNTHETIC HORMONES MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 152. BRICS SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 153. BRICS SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 154. BRICS SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 155. BRICS SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2017-2032 (USD MILLION)
TABLE 156. BRICS SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 157. BRICS SYNTHETIC HORMONES MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 158. EUROPEAN UNION SYNTHETIC HORMONES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 159. EUROPEAN UNION SYNTHETIC HORMONES MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 160. EUROPEAN UNION SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 161. EUROPEAN UNION SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 162. EUROPEAN UNION SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 163. EUROPEAN UNION SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2017-2032 (USD MILLION)
TABLE 164. EUROPEAN UNION SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 165. EUROPEAN UNION SYNTHETIC HORMONES MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 166. ASEAN SYNTHETIC HORMONES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 167. ASEAN SYNTHETIC HORMONES MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 168. ASEAN SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 169. ASEAN SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 170. ASEAN SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 171. ASEAN SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2017-2032 (USD MILLION)
TABLE 172. ASEAN SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 173. ASEAN SYNTHETIC HORMONES MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 174. GCC SYNTHETIC HORMONES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 175. GCC SYNTHETIC HORMONES MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 176. GCC SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 177. GCC SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 178. GCC SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 179. GCC SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2017-2032 (USD MILLION)
TABLE 180. GCC SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 181. GCC SYNTHETIC HORMONES MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 182. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 183. CHINA SYNTHETIC HORMONES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 184. CHINA SYNTHETIC HORMONES MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 185. CHINA SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 186. CHINA SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 187. CHINA SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 188. CHINA SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2017-2032 (USD MILLION)
TABLE 189. CHINA SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 190. CHINA SYNTHETIC HORMONES MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 191. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 192. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 193. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 194. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 195. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 196. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2017-2032 (USD MILLION)
TABLE 197. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 198. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 199. JAPAN SYNTHETIC HORMONES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 200. JAPAN SYNTHETIC HORMONES MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 201. JAPAN SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 202. JAPAN SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 203. JAPAN SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 204. JAPAN SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2017-2032 (USD MILLION)
TABLE 205. JAPAN SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 206. JAPAN SYNTHETIC HORMONES MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 207. INDIA SYNTHETIC HORMONES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 208. INDIA SYNTHETIC HORMONES MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 209. INDIA SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 210. INDIA SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 211. INDIA SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 212. INDIA SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2017-2032 (USD MILLION)
TABLE 213. INDIA SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 214. INDIA SYNTHETIC HORMONES MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 215. GERMANY SYNTHETIC HORMONES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 216. GERMANY SYNTHETIC HORMONES MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 217. GERMANY SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 218. GERMANY SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 219. GERMANY SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 220. GERMANY SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2017-2032 (USD MILLION)
TABLE 221. GERMANY SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 222. GERMANY SYNTHETIC HORMONES MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 223. UNITED KINGDOM SYNTHETIC HORMONES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 224. UNITED KINGDOM SYNTHETIC HORMONES MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 225. UNITED KINGDOM SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 226. UNITED KINGDOM SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 227. UNITED KINGDOM SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 228. UNITED KINGDOM SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2017-2032 (USD MILLION)
TABLE 229. UNITED KINGDOM SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 230. UNITED KINGDOM SYNTHETIC HORMONES MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 231. AUSTRALIA SYNTHETIC HORMONES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 232. AUSTRALIA SYNTHETIC HORMONES MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 233. AUSTRALIA SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 234. AUSTRALIA SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 235. AUSTRALIA SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 236. AUSTRALIA SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2017-2032 (USD MILLION)
TABLE 237. AUSTRALIA SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 238. AUSTRALIA SYNTHETIC HORMONES MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 239. FRANCE SYNTHETIC HORMONES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 240. FRANCE SYNTHETIC HORMONES MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 241. FRANCE SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 242. FRANCE SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 243. FRANCE SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 244. FRANCE SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2017-2032 (USD MILLION)
TABLE 245. FRANCE SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 246. FRANCE SYNTHETIC HORMONES MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 247. SOUTH KOREA SYNTHETIC HORMONES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 248. SOUTH KOREA SYNTHETIC HORMONES MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 249. SOUTH KOREA SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 250. SOUTH KOREA SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 251. SOUTH KOREA SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 252. SOUTH KOREA SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2017-2032 (USD MILLION)
TABLE 253. SOUTH KOREA SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 254. SOUTH KOREA SYNTHETIC HORMONES MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 255. ITALY SYNTHETIC HORMONES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 256. ITALY SYNTHETIC HORMONES MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 257. ITALY SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 258. ITALY SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 259. ITALY SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 260. ITALY SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2017-2032 (USD MILLION)
TABLE 261. ITALY SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 262. ITALY SYNTHETIC HORMONES MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 263. CANADA SYNTHETIC HORMONES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 264. CANADA SYNTHETIC HORMONES MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 265. CANADA SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 266. CANADA SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 267. CANADA SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 268. CANADA SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2017-2032 (USD MILLION)
TABLE 269. CANADA SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 270. CANADA SYNTHETIC HORMONES MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 271. RUSSIA SYNTHETIC HORMONES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 272. RUSSIA SYNTHETIC HORMONES MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 273. RUSSIA SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 274. RUSSIA SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 275. RUSSIA SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 276. RUSSIA SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2017-2032 (USD MILLION)
TABLE 277. RUSSIA SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 278. RUSSIA SYNTHETIC HORMONES MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 279. BRAZIL SYNTHETIC HORMONES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 280. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 281. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 282. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 283. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 284. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2017-2032 (USD MILLION)
TABLE 285. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 286. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 287. MEXICO SYNTHETIC HORMONES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 288. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 289. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 290. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 291. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 292. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2017-2032 (USD MILLION)
TABLE 293. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 294. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 295. SPAIN SYNTHETIC HORMONES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 296. SPAIN SYNTHETIC HORMONES MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 297. SPAIN SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 298. SPAIN SYNTHETIC HORMONES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 299. SPAIN SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 300. SPAIN SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2017-2032 (USD MILLION)
TABLE 301. SPAIN SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 302. SPAIN SYNTHETIC HORMONES MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 303. GLOBAL SYNTHETIC HORMONES MARKET SHARE, BY KEY PLAYER, 2025
TABLE 304. GLOBAL SYNTHETIC HORMONES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

Companies Mentioned

  • Abbott Laboratories
  • AbbVie Inc.
  • Amneal Pharmaceuticals, Inc.
  • AstraZeneca PLC
  • Aurobindo Pharma Ltd.
  • Bayer AG
  • Besins Healthcare
  • Dr. Reddy’s Laboratories
  • Eli Lilly and Company
  • Endo International plc
  • Ferring B.V.
  • Gedeon Richter Plc
  • Gilead Sciences Inc.
  • IBSA Group
  • Ipsen S.A.
  • Johnson & Johnson Services Inc.
  • Lupin Limited
  • Mayne Pharma Group
  • Merck & Co. Inc.
  • Novartis AG
  • Novo Nordisk A/S
  • Organon & Co.
  • Pfizer Inc.
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Theramex
  • TherapeuticsMD Inc.
  • Viatris Inc.
  • Zydus Lifesciences Ltd.

Table Information

Report AttributeDetails
No. of Pages188
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 9.91 Billion
Forecasted Market Value ( USD ) by 2032 $ 15.78 Billion
Compound Annual Growth Rate8.0%
Regions CoveredGlobal
No. of Companies Mentioned30

Related Topics

Related Reports

Human Growth Hormone Market - Global Forecast 2026-2032 - Product Image

Human Growth Hormone Market - Global Forecast 2026-2032

  • Report
  • 193 Pages
  • Global
From
Synthetic Hormones Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Synthetic Hormones Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Synthetic Hormones Market Report 2026 - Product Image

Synthetic Hormones Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Synthetic Hormones Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F - Product Image

Synthetic Hormones Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

  • Report
  • 177 Pages
  • Global
From
Bioidentical Hormones Market - Global Forecast 2026-2032 - Product Image

Bioidentical Hormones Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From

About the Synthetic Hormone Market

The Synthetic Hormone market is a subset of the Endocrine and Metabolic Disorders Drugs market. Synthetic Hormones are drugs that are designed to mimic the effects of naturally occurring hormones in the body. These drugs are used to treat a variety of endocrine and metabolic disorders, such as diabetes, thyroid disorders, and growth hormone deficiencies. Synthetic Hormones are also used to treat menopausal symptoms, such as hot flashes and night sweats. Synthetic Hormones are typically administered orally, through injections, or through topical creams. The market for Synthetic Hormones is expected to grow in the coming years due to the increasing prevalence of endocrine and metabolic disorders, as well as the aging population. Some companies in the Synthetic Hormone market include Novo Nordisk, Eli Lilly, Merck, Pfizer, and Sanofi. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.